AGP Executive Report
Last update: 11 hours agoCBD & Alzheimer’s Research: A new study in eNeuro suggests inhaled CBD may help calm brain inflammation linked to Alzheimer’s, targeting neuroimmune overactivation in a mouse model. Medical Access Expansion: Kentucky’s Speakeasy Dispensary says it will open in Bowling Green on June 5 to close a regional gap for registered patients. Regulation Shock (Delta-8): Texas Delta-8 products shift toward Schedule I treatment after a court move ended a long-running injunction, leaving retailers waiting on state guidance. Legal/Market Updates: California’s legal cannabis sales are reported to have generated about $248M in tax revenue in the first quarter of 2026. Policy Watch: A “Cannabis And Psychedelics Bill Roundup” highlights ongoing legislative momentum and disputes across multiple states. Community & Compliance: Victoria’s Cannabis Buyers Club faces further action tied to licensing and permits, with supporters pushing for judicial review. Wellness Angle: A clinical study on chronic arthritis pain reports meaningful pain declines with cannabinoid capsules while tracking cognitive effects.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
